Sulindac for Patients With AML

Clinical trial NCT01843179 · WITHDRAWN

Trial details

NCT number: NCT01843179
Sponsor: Massachusetts General Hospital
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2014-01-01
Primary completion: 2014-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.